Human synaptotagmin-II is not a high affinity receptor for botulinum neurotoxin B and G: increased therapeutic dosage and immunogenicity. FEBS Lett. 2012 Feb 17;586(4):310-3 Willjes G , Mahrhold S, Strotmeier
, Middendorff, R., Loveland, K.L., Hedger, M.P., Meinhardt, A. (2019). Dexamethasone improves therapeutic outcomes in a preclinical bacterial epididymitis mouse model. Hum. Reprod. 34, 1195-1205. Scharf
Rasmussen BB, Lokau J, Lenk L, Garbers C, Feuerhake F , Rose-John S, Waetzig GH, Rosenstiel P. Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory
Explored as Potential Treatment Option in Diabetic Retinopathy: Clinical Concept and Methodology.” Therapeutic Advances in Endocrinology and Metabolism 10:204201881989188. doi: 10.1177/2042018819891886. Trudzinski
R., Koenecke, C., & Schultze-Florey, C. R. (2022). Spectral flow cytometry cluster analysis of therapeutic donor lymphocyte infusions identifies T cell subsets associated with outcome in patients with AML
Langhof H, Chin WWL, Wieschowski S, Federico C, Kimmelman J, Strech D. Preclinical efficacy in therapeutic area guidelines from the U.S. Food and Drug Administration and the European Medicines Agency: a